Literature DB >> 8324124

Role of the laboratory in investigations of Clostridium difficile diarrhea.

J S Brazier1.   

Abstract

The laboratory diagnosis of acute diarrhea due to Clostridium difficile can be based solely on the demonstration of either cytotoxin or enterotoxin in the stool. This and other noncultural methods, however, fail to provide isolates from which useful data can be obtained. Outbreaks can be recognized only by comparison of isolated strains. A dual approach of toxin detection and isolation is therefore recommended.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324124     DOI: 10.1093/clinids/16.supplement_4.s228

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces.

Authors:  J Freeman; M H Wilcox
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

2.  Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.

Authors:  A Lozniewski; C Rabaud; E Dotto; M Weber; F Mory
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Usefulness of culture in the diagnosis of Clostridium difficile infection.

Authors:  T V Riley; R A Bowman; C L Golledge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

4.  PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

Authors:  S L Stubbs; J S Brazier; G L O'Neill; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 5.  Diagnosis and management of Clostridium difficile infection.

Authors:  S Tabaqchali; P Jumaa
Journal:  BMJ       Date:  1995-05-27

6.  Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.

Authors:  B Kullin; J Wojno; V Abratt; S J Reid
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-30       Impact factor: 3.267

7.  Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.

Authors:  Roosa Savolainen; Juha M Koskinen; Silja Mentula; Janne O Koskinen; Suvi-Sirkku Kaukoranta
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

8.  Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom.

Authors:  Fabio Miyajima; Paul Roberts; Andrew Swale; Valerie Price; Maureen Jones; Michael Horan; Nicholas Beeching; Jonathan Brazier; Christopher Parry; Neil Pendleton; Munir Pirmohamed
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

9.  Effectiveness of various cleaning and disinfectant products on Clostridium difficile spores of PCR ribotypes 010, 014 and 027.

Authors:  N Kenters; E G W Huijskens; S C J de Wit; I G J M Sanders; J van Rosmalen; E J Kuijper; A Voss
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-03       Impact factor: 4.887

10.  Clostridium difficile in patients attending tuberculosis hospitals in Cape Town, South Africa, 2014-2015.

Authors:  Brian R Kullin; Sharon Reid; Valerie Abratt
Journal:  Afr J Lab Med       Date:  2018-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.